Concepedia

Publication | Open Access

Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

DOIFull Paper Access

75

Citations

53

References

2011

Year

Caroline H. Diep, Rubén M. Muñoz, Ashish Choudhary, Daniel D. Von Hoff, Haiyong Han
Clinical Cancer Research

Abstract

Overall, our results suggest that combination therapy of an EGFR and MEK inhibitors may have enhanced efficacy in patients with pancreatic cancer.

References

YearCitations

Page 1